ICW Investment Advisors LLC Has $1.65 Million Stock Holdings in The Clorox Company (NYSE:CLX)

ICW Investment Advisors LLC lifted its stake in shares of The Clorox Company (NYSE:CLX) by 1.4% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 10,155 shares of the company’s stock after buying an additional 141 shares during the quarter. ICW Investment Advisors LLC’s holdings in Clorox were worth $1,649,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently modified their holdings of the stock. Congress Wealth Management LLC DE lifted its stake in shares of Clorox by 26.9% during the 4th quarter. Congress Wealth Management LLC DE now owns 2,952 shares of the company’s stock worth $479,000 after buying an additional 626 shares during the last quarter. Vanguard Group Inc. lifted its stake in shares of Clorox by 0.8% during the 4th quarter. Vanguard Group Inc. now owns 15,507,152 shares of the company’s stock worth $2,518,517,000 after buying an additional 124,428 shares during the last quarter. Stevens Capital Management LP lifted its stake in shares of Clorox by 32.1% during the 4th quarter. Stevens Capital Management LP now owns 6,595 shares of the company’s stock worth $1,071,000 after buying an additional 1,602 shares during the last quarter. KLP Kapitalforvaltning AS acquired a new stake in Clorox in the 4th quarter worth about $6,744,000. Finally, AXQ Capital LP acquired a new stake in Clorox in the 4th quarter worth about $447,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Trading Down 0.3 %

Shares of Clorox stock opened at $144.88 on Monday. The firm has a market capitalization of $17.85 billion, a PE ratio of 39.58, a price-to-earnings-growth ratio of 2.62 and a beta of 0.45. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The firm’s 50 day moving average is $152.84 and its 200 day moving average is $159.74. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter last year, the firm posted $2.16 EPS. Equities research analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.37%. The ex-dividend date is Wednesday, April 23rd. Clorox’s payout ratio is 133.33%.

Analysts Set New Price Targets

CLX has been the subject of several analyst reports. DA Davidson dropped their price objective on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research note on Wednesday, February 5th. Wells Fargo & Company lifted their price objective on shares of Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 4th. JPMorgan Chase & Co. lifted their price objective on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. Finally, Barclays lifted their price objective on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research note on Wednesday, February 5th. Three investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $159.62.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.